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Abstract: We have previously shown a tissue-specific increase in oxidative stress in the 
early stages of streptozotocin (STZ)-induced diabetic rats. In this study, we investigated 
oxidative  stress-related  long-term  complications  and  mitochondrial  dysfunctions  in  the 
different tissues of STZ-induced diabetic rats (>15 mM blood glucose for 8 weeks). These 
animals showed a persistent increase in reactive oxygen and nitrogen species (ROS and 
RNS, respectively) production. Oxidative protein carbonylation was also increased with 
the  maximum  effect  observed  in  the  pancreas  of  diabetic  rats.  The  activities  of 
mitochondrial respiratory enzymes ubiquinol: cytochrome c oxidoreductase (Complex III) 
and  cytochrome  c  oxidase  (Complex  IV)  were  significantly  decreased  while  that  of 
NADH:ubiquinone oxidoreductase (Complex I) and succinate:ubiquinone oxidoreductase 
(Complex  II)  were  moderately  increased  in  diabetic  rats,  which  was  confirmed  by  the 
increased expression of the 70 kDa Complex II sub-unit. Mitochondrial matrix aconitase, a 
ROS  sensitive  enzyme,  was  markedly  inhibited  in  the  diabetic  rat  tissues.  Increased 
expression of oxidative stress marker proteins Hsp-70 and HO-1 was also observed along 
with increased expression of nitric oxide synthase. These results suggest that mitochondrial 
respiratory complexes  may play a  critical role in ROS/RNS homeostasis and oxidative 
stress related changes in type 1 diabetes and may have implications in the etiology of 
diabetes and its complications. 
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Abbreviations 
DCFDA, 2‟,7‟-dichlorofluorescein diacetate;  
DNPH, 2,4-dinitrophenylhydrazine;  
GSH, glutathione; 
NO, nitric oxide;  
NOS, nitric oxide synthase; 
ROS, reactive oxygen species;  
STZ, streptozotocin;  
SDS-PAGE, sodium dodecylsulfate polyacrylamide gel electrophoresis. 
1. Introduction 
Increased oxidative stress has been implicated in the etiology (especially type 1) and pathology 
(both  type  1  and  type  2)  of  diabetic  complications  [1–3].  In  diabetes,  hyperglycemia,  increased 
production  of  reactive  oxygen  and  nitrogen  species  (ROS  and  RNS),  increased  protein  glycation, 
increased lipolysis, ketogenesis and decreased antioxidants, glutathione (GSH) and NAD(P)H have all 
been  reported  to  be  involved  [4–8].  Pancreatic  beta  cells  exposed  to  hyperglycemia  and  reactive 
oxygen species displayed reduced insulin secretion and increased insulin resistance [9]. It has been 
proposed that during the early stages of beta cell destruction, hyperglycemia-induced mitochondrial 
overwork and alterations in the rate of oxygen utilization by respiratory chain complexes are possible 
mechanisms  for  development  of  diabetes-related  complications.  It  is  therefore  suggested  that 
suppression of oxidative stress in beta cells may prevent or delay the onset of type 1 and progression of 
type  2  diabetes  and  related  complications.  Several  studies  have  also  shown  that  treatment  with 
antioxidants protects against the onset of diabetes [10–12].  
Mitochondria undergo rapid fragmentation with a concomitant increase in ROS formation after 
exposure to high glucose concentrations [12]. Increased ROS formation in mitochondria may also lead 
to disturbance of mitochondrial bioenergetics due to mutations in mitochondrial (mt) DNA and altered 
electron  flow  through  respiratory  complexes  [13–15].  Increased  ROS  production  has  also  been 
reported  to  inhibit  aconitase,  an  enzyme  which  protects  mtDNA  from  degradation  [16,17]. 
Complications associated with diabetes are augmented by increased O2 consumption, ROS production, 
lipid peroxidation and decreased mitochondrial antioxidant substrates (GSH, NADH, CoQ, etc) [18–20]. 
It  has  been  reported  that  diabetic  rats  display  higher  O2  consumption  and  reduced  mitochondrial 
antioxidant GSH and coenzyme Q pools than non-diabetic rats [19]. An increased Ca
2+ uptake and 
altered  mitochondrial  transmembrane  potential  in  tissues  from  diabetic  animals  are  the  other  key 
factors  responsible  for  disturbance  in  mitochondrial  bioenergetics.  Consequently,  prevention  of 
mitochondrial oxidative damage and ROS production may have therapeutic potential. 
It is known that diabetic complications and increased oxidative stress are tissue-specific and are 
accompanied by altered glucose transport, mitochondrial oxygen metabolism and energy production [21]. Int. J. Mol. Sci. 2011, 12      3135 
 
 
However, specific sites of ROS generation along the electron transport chain are controversial. Thus, 
in some tissues it seems that inhibition of electron transfer at Complex I (by rotenone) may generate an 
increase in radical formation, whereas, in others, rotenone will reduce radical generation by preventing 
passage of electrons further into the distal part of the chain. The basis for such a difference is obscure 
and presumed to be related to changes in mitochondrial membrane potential and leakage of radicals 
across the membranes [21,22]. We have previously shown that increased superoxide production during 
the early stages of STZ-induced diabetes (4 weeks) is in part related to decreased GSH pool and 
altered electron flow from NADH in the mitochondria [23]. In the present study, we have further 
elucidated the role of mitochondrial respiratory complexes and alterations in mitochondrial oxidative 
stress in chronically hyperglycemic (8 weeks) STZ-induced diabetic rats. 
2. Results and Discussion 
2.1. Induction of Chronic Diabetes 
At the end of 8 weeks of STZ-treatment, the blood glucose level of control (vehicle alone) rats 
ranged from 5.2 mM to 5.8 mM (n = 6, average body wt. 300–360 g). On the other hand, blood sugar 
levels of rats with chronic diabetes (hereafter called diabetic rats) ranged from 16.7 mM to 21.2 mM 
with an average body wt. 125–150 g. Of the six diabetic rats, one died at week 6 and one had blood 
sugar level less than 10 mM. Therefore, the values for diabetic rats were calculated from 4 rats that 
maintained chronic hyperglycemia throughout the experiment. 
2.2. Sub-Cellular Oxidative Stress 
Increased peroxide production was observed in the different sub-cellular compartments of tissues 
from  diabetic  rats  (Figure  1).  A  significant  increase  (30–100%;  P  <  0.05)  in  mitochondrial  ROS 
formation was seen in all tissues (Figure 1a). Pancreas and kidney exhibited maximum increase in 
ROS  formation  while  liver  and  brain  showed  about  25–35%  increase  in  the  level  of  peroxides. 
Microsomal ROS production (Figure 1b) was increased markedly (about 2-fold) in the liver and brain 
while about 30% increase was seen in the pancreas and kidney of diabetic rats. A significant increase 
in cytosolic (Figure 1c) peroxide level was also seen in the pancreas and kidney while brain and liver 
had a marginal increase only. These results indicate increased ROS production in all the tissues in 
diabetic  rats.  There  appears  to  be  a  greater  increased  ROS  production  in  the  mitochondria  and 
microsomes  than  the  cytosolic  fraction.  The  level  of  ROS  in  pancreas  and  kidney  appear  to  be 
markedly  increased  suggesting  that  they  are  the  major  target  tissues  for  diabetes-induced  
oxidative stress. Int. J. Mol. Sci. 2011, 12      3136 
 
 
Figure  1.  Reactive  oxygen  species  (ROS)  production  in  streptozotocin  (STZ)-induced 
diabetes. Mitochondria (50 µ g protein) (a), microsomes (100 µ g) (b) and cytosols (100 µ g) (c) 
from pancreas (P), liver (L), kidney (K) and brain (B) tissues from control  and diabetic 
rats were used for the measurement of ROS by the modified DCFDA method as described 
before [24]. The values are mean  S.E.M. of three individual experiments. * indicate 
significant difference (P < 0.05) from control animals. (□) Control; (■) Diabetic. 
     
(a)            (b)        (c)  
2.3. Nitric Oxide (NO) Production 
A differential increase in NO production was also seen in tissues from diabetic rats (Figure 2). 
Mitochondria (Figure 2a), microsomes (Figure 2b) and cytosol (Figure 2c) from pancreas, liver and 
kidney showed a significant increase (22–33%; P < 0.05) in NO production while these fractions from 
the brain showed a marginal increase (7–12%, P > 0.05). 
Figure  2.  Reactive  nitrogen  species  (RNS)  production  in  STZ-induced  diabetes. 
Mitochondrial (a), microsomal (b) and cytosolic (c) proteins (100 µg) from pancreas (P), 
liver (L), kidney (K) and brain (B) of control and diabetic rats were analyzed for total NO 
level by Griess Reagent using a kit from Calbiochem as described in the Materials and 
Methods. The values are mean  S.E.M. for three determinations. * indicate significant 
difference (P < 0.05) from control animals. (□) Control; (■) Diabetic. 
      
(a)        (b)          (c)  
2.4. Oxidative Carbonylation of Proteins 
Tissues  from  diabetic  rats  exhibited  a  modest  but  significant  increase  (20–35%;  P  <  0.05)  in 
oxidative carbonylation of proteins (Figure 3). Mitochondria from pancreas and kidney (Figure 3a) 
appear to be more affected (30–35% increase) than liver and brain (~20% increase). On the other hand, Int. J. Mol. Sci. 2011, 12      3137 
 
 
a marked increase in microsomal protein carbonylation in pancreas, liver and kidney (about 2–3 fold) 
was observed, while brain exhibited only about a 20% increase in carbonylated proteins (Figure 3b). 
Cytosolic fraction also showed a significant increase in protein carbonylation in pancreas and kidney 
from diabetic tissues while brain and liver exhibited a marginal increase (15–20%) (Figure 3c). 
Figure 3. Protein carbonylation in STZ-induced diabetes. Mitochondrial (a), microsomal 
(b) and cytosolic (c) proteins (100 µg each) from pancreas (P), liver (L), kidney (K) and 
brain (B) of control and diabetic rats were incubated with 2 mM DNPH in 1.0 mL assay 
system for 1 h. The DNPH-coupled carbonylated proteins were then precipitated by 10% 
ice-cold TCA and washed three times with ethanol: ethyl acetate to remove free DNPH. 
The DNPH-coupled proteins were then dissolved in 6 M guanidine-HCl and absorption 
read at 366 nm. Results were calculated based on the molar extinction coefficient of 22,000 
as  described  in  the  Materials  and  Methods.  The  values  are  mean    S.E.M.  for  three 
determinations.  *  indicate  significant  difference  (P  <  0.05)  from  the  control  animals.  
(□) Control; (■) Diabetic. 
 
(a)            (b)        (c)  
2.5. Respiratory Chain Activities 
Figure  4  shows  alterations  in  the  activities  of  mitochondrial  respiratory  complexes.  On  a 
comparative basis, kidney and liver showed the highest activities for all the four complexes studied. 
Complex I and II activities in the tissues from diabetic rats were moderately increased (20–30% from 
control;  P  <  0.05).  Brain,  however,  showed  no  increase  in  Complex  II  activity.  The  activities  of 
Complex III and IV from diabetic rats were, however, significantly decreased (25–36%; P < 0.05) in 
pancreas, liver and kidney. Brain, however, showed no significant inhibition (7–10%; P > 0.05) in 
these activities. Int. J. Mol. Sci. 2011, 12      3138 
 
 
Figure  4.  Activities  of  respiratory  complexes  in  STZ-induced  diabetes.  Mitochondrial 
protein (10–25 µg) from pancreas, liver, kidney and brain of control and diabetic rats were 
used for the assays of respiratory chain enzyme complexes as described in the Materials 
and Methods. (a) Complex I, NADH: ubiquinone oxidoreductase activity; (b) Complex II, 
succinate:ubiquinone oxidoreductase activity; (c) Complex III, ubiquinol: ferrocytochrome 
c oxidoreductase activity; and (d) Complex IV, cytochrome c oxidase activity. The values 
are mean  S.E.M for three determinations. * indicate significant difference (P < 0.05) 
from the controls. (□) Control; (■) Diabetic. 
 
(a)          (b)  
 
(c)         (d)  
2.6. Mitochondrial O2 Consumption 
We also determined O2 consumption as an index for mitochondrial respiratory function in diabetic 
rats. As shown in Figure 5a, the ADP-coupled State 3 respiration was increased in all the tissues in 
diabetic rats. However, the respiratory control ratio (RCR) of State 3 over State 4 was significantly 
inhibited (18–32%; P < 0.05) in diabetic rats (Figure 5b). Int. J. Mol. Sci. 2011, 12      3139 
 
 
Figure 5. Succinate-dependent oxygen uptake by mitochondria from control and diabetic 
rats.  Succinate-dependent  oxygen  consumption  by  freshly  prepared  mitochondria  from 
control  and  diabetic  rats  in  the  presence  (State  3)  or  absence  of  ADP  (State  4)  was 
measured as described in the Materials and Methods (a). Respiratory Control Rate (RCR) 
was  calculated  as  the  ratio  of  State  3/State  4  respiration  (b)  and  expressed  relative  to 
control rats. The values are mean  S.E.M. of three independent experiments. * indicate 
significant difference (P < 0.05) from control animals. (□) Control; (■) Diabetic. 
 
 (a)             (b) 
2.7. Mitochondrial Aconitase Activity 
Inhibition of mitochondrial aconitase is used as a marker for superoxide detection. Other ROS, 
including H2O2, can also inactivate  aconitase. Thus, the assay for aconitase activity is a sensitive 
marker of mitochondrial-generated ROS level [25]. Figure 6 shows mitochondrial aconitase activity in 
diabetic tissues after STZ-treatment. A significant decrease (42%; P < 0.05) in aconitase activity was 
observed in pancreas followed by kidney (28%). In contrast, liver (16%) and brain (20%) showed only 
a moderate decrease in the activity. 
Figure  6.  Mitochondrial  aconitase  activity  in  control  and  diabetic  rats.  100  µg  of 
mitochondrial protein was incubated in a 1.0 mL reaction system containing citrate and 
NADP coupled with isocitrate dehydrogenase to monitor the rate of NADPH formation as 
described  in  the  Materials  and  Methods.  The  values  are  mean    S.E.M.  of  three 
independent experiments. * indicate significant difference (P < 0.05) from control animals. 
(□) Control; (■) Diabetic. 
 Int. J. Mol. Sci. 2011, 12      3140 
 
 
2.8. Expression of Complex II, HO-1, Hsp-70 and iNOS in Mitochondria 
In  order  to  determine  the  increase  in  oxidative  stress  and  whether  the  increased  mitochondrial 
formation  of  NO  in  STZ-treated  diabetic  rats  was  due  to  mitochondrial  NOS,  we  carried  out 
immunoblot analysis of mitochondrial proteins from control and experimental rat tissues using iNOS 
antibody. Although not  shown here, mitochondria from different rat tissues exhibited  a maximum 
interaction with iNOS antibody when compared with nNOS or eNOS antibodies. As shown in Figure 7, 
the maximum induction in the level of mitochondrial NOS was observed in the pancreas (~4 fold), 
followed by the liver (~2.5 fold), kidney (1.5 fold) and brain (1.6 fold). An increased expression was 
also seen with other oxidative stress marker proteins, Hsp-70 and HO-1. An increased expression of 
the 70 kDa subunit of the mitochondrial Complex II was confirmation of an increased catalytic activity 
in the tissues from diabetic rats. 
Figure 7. Mitochondrial level of Complex II, HO-1, Hsp-70, and iNOS in STZ-induced 
diabetic rats. Mitochondrial proteins (50 µg) from pancreas, liver, kidney and brain of 
control (C) and diabetic rats (D) were resolved by 12% SDS-PAGE and transferred on to 
nitrocellulose paper by Western blot analysis. The blot was probed with iNOS, Hsp-70, 
HO-1  and  Complex  II  antibodies.  Tim23  was  used  as  a  loading  control.  For  relative 
quantitative comparison, the intensity of the control band in each case was regarded as 1. 
The blot shown is a typical representation of at least three experiments. 
 
2.9. Discussion 
Altered activities of respiratory enzymes and aerobic O2 utilization are critical processes for ROS 
production  under  physiological  conditions.  Production  of  ROS  is  markedly  enhanced  in  many 
pathological conditions in which the respiratory chain is impaired. High blood glucose level induces 
overproduction  of  ROS  by  mitochondrial  electron  transport  chain  during  respiration.  Increasing 
evidence suggests that there is  a close link  between hyperglycemia, oxidative stress,  and diabetic Int. J. Mol. Sci. 2011, 12      3141 
 
 
complications [1–8]. We have previously shown altered mitochondrial GSH metabolism and increased 
ROS production in mitochondria under increased oxidative stress conditions and in diabetes [23,24,26,27]. 
However, in this study we have shown that under chronic hyperglycemic conditions, mitochondrial 
oxidative stress plays a critical role in maintaining homeostasis of mitochondrial oxygen consumption. 
A moderate increase in NADH- and succinate- dependent Complex I and II activities respectively, 
indicate an excessive electron flow in the mitochondria of chronic diabetic rat tissues characterized by 
severe  hyperglycemia.  This  increase  may  presumably  be  due  to  availability  of  excess  substrates 
(glucose, fatty acids and other metabolites) in diabetes. The role and contribution of mitochondrial 
complexes in ROS production is still not clear. Both Complexes I and III have been reported to be 
directly involved in ROS production, which is dependent on a number of factors, including the number 
of  carriers,  electron  supply  and  release  of  electrons  from  each  carrier.  These  factors,  in  turn, are 
affected by the biological state of tissues, respiratory rate, reverse electron flow, inner membrane 
potential, oxidation of mitochondrial glutathione and post-translational modification of the complexes. 
Studies have shown that inhibition of Complex I activity is not necessarily involved in  increased 
production of ROS from intact mitochondria which was suggested to be due to the reverse electron 
flow [28,29]. Our results have shown increased Complex I/II and decreased Complex III/IV activities, 
which presumably increased the back flow of  electrons  causing increase in  ROS  production.  Our 
previous study, on STZ-model animals, has also indicated a moderate increase in Complex I activity 
and  a  decrease  in  Complex  IV  (cytochrome  c  oxidase)  activity  accompanied  by  increased  ROS 
production presumably due to the increased back flow/leakage of electrons [23]. This observation was 
further confirmed in our present study. There are several studies including our own suggesting that 
altered respiratory complex activities lead to increased production of ROS [23,24,30–35]. There are 
also reports which support the increase in succinate-dependent mitochondrial respiration at Complex II 
site and inhibition of Complex IV activity in STZ-treated diabetic rats [6,23,36].We have recently 
shown that under hypoxic conditions or ischemia, a reduced cytochrome  c oxidase (Complex IV) 
activity augments the production of ROS [24]. Studies have also shown that alteration in mitochondrial 
GSH and ROS/RNS play an important role in regulating the activities of respiratory complexes under 
oxidative stress conditions [17,23,33]. 
In diabetes, lowering of body pH due to ketoacidosis may also be related to altered mitochondrial 
membrane potential and oxygen utilization. We have presented evidence indicating a decrease in the 
ratio of State 3 over State 4 respiration (RCR) in diabetic rat tissues. These results suggest altered 
bioenergetics in the mitochondria in diabetic rats presumably due to altered oxygen metabolism by 
respiratory complexes and increased production of ROS/RNS [37–39]. 
The inhibition of mitochondrial aconitase by direct interaction with superoxides and other ROS is 
thought to be an index of mitochondrial oxidative stress [17,25,29]. There are several reports showing 
inhibition  of  aconitase  activity  by  increased  ROS  production  when  activities  of  mitochondrial 
respiratory  complexes  are  altered  [17,31,40].  Thus,  in  STZ-induced  diabetes,  the  inhibition  of 
aconitase,  an  enzyme  which  protects  mitochondrial  DNA  as  well,  might  be  implicated  with  the 
increased mitochondrial genetic and metabolic stresses. 
Increase  in  mitochondrial  oxidative  stress  in  ischemia  and  hypoxia,  depletion  of  GSH  and 
mitochondrial DNA, increased production of ROS and NO have all been linked to increased oxidative 
carbonylation of mitochondrial proteins [37,41]. Our results also showed increased carbonylation of Int. J. Mol. Sci. 2011, 12      3142 
 
 
proteins in the mitochondria and extramitochondrial compartments of tissues from diabetic rats. The 
level of carbonylation was, however, higher in the microsomes than mitochondria or cytosol. This is 
presumably due to differences in antioxidant pools in different compartments. The differences in NO 
pools in different compartments can also be associated with differential carbonylation of proteins. NO 
is  synthesized  by  different  isoforms  of  NOS.  In  this  study,  we  show  that  NO  concentration  is 
differentially increased in different tissues in diabetes, which was also supported by increased NOS 
protein level in the mitochondria from diabetic rats. Studies have shown alterations in mitochondrial 
GSH pool and glutathione S-transferase enzyme in diabetes which may also affect the NO pool in 
mitochondria [23,38,39,42,43]. In the present study, we investigated the role of specific mitochondrial 
respiratory complexes in the regulation of ROS and RNS pools and associated consequences from 
altered mitochondrial respiratory and redox functions. 
3. Experimental Section 
3.1. Materials 
Cytochrome c,  isocitrate, isocitrate dehydrogenase, 2,4-dinitrophenylhydrazine (DNPH), NADH, 
NADP  and  lauryl  maltoside  were  purchased  from  Sigma  (St  Louis,  MO,  USA).  
2‟,7‟-Dichlorofluorescein diacetate (DCFDA) and antibody for 70 kDa sub-unit of Complex II were 
purchased from Molecular Probes, Inc. (Eugene, OR, USA). Kits for nitric oxide assay were procured 
from Calbiochem (CN Biosciences Inc, La Jolla, CA, USA). Antibodies for iNOS, Hsp-70, HO-1 and 
Tim 23 were purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA). Reagents for 
electrophoresis and Western blot analyses were purchased from  Bio-Rad Laboratories (Richmond,  
CA, USA). 
3.2. Treatment of Animals and Sub-Cellular Fractionation 
Male Sprague-Dawley adult rats (150–200 g; n = 6) were purchased from Harlan and maintained at 
20–25 C on a 12 h light and dark cycle with access to water and food ad libitum. Diabetes was 
induced with a single dose of STZ (60 mg/kg body weight, I.P. in 0.1 M citrate buffer, pH 4.5) as 
described before [23]. Control rats were given vehicle alone. All animals were treated according to the 
“Guiding Principles in Care and Use of Animals” and the Guide for the Care and Use of Laboratory 
Animals adopted by the National Institute of Health and approved by Institutional Research Board. The 
rats were maintained for 8 additional weeks with water and food ad libitum. STZ-treated rats were 
considered chronically diabetic if their blood sugar level was maintained at >15 mM at the termination 
of the experiment (8 weeks). At the end of the experimental period, rats were sacrificed and their 
pancreas, liver, kidney, and brain were removed for further processing. Mitochondria, microsomes and 
cytosol  were  prepared  by  differential  centrifugation  and  the  purity  of  mitochondria  and  other  
sub-cellular fractions were ascertained by measuring marker enzymes as described before [23]. The 
fractions containing less than 5% cross contaminations were used for further analysis. Protein content 
was measured by the method of Lowry et al. [44] using BSA as standard. Int. J. Mol. Sci. 2011, 12      3143 
 
 
3.3. Assays for Reactive Oxygen and Nitrogen Species (ROS and RNS) 
We have recently described the modifications made to the DCFDA dependent fluorescence method 
for assaying the level of ROS in different sub-cellular fractions including mitochondria [23,24]. Since 
mitochondrial superoxides are easily converted to hydrogen peroxide by superoxide dismutase in the 
mitochondrial inner membrane space and in the matrix, we used the DCFDA method (5 µM DCFDA 
in  1.0  mL  assay  containing  50  µg  of  proteins  from  mitochondria,  microsomes  and  cytosol)  as 
described  before  [24]  for  determination  of  total  peroxides  produced  in  the  tissues  of  control  and 
diabetic rats. The validity of the method for detection of superoxides and peroxides were tested by 
adding  superoxide dismutase (SOD) and catalase to  the reaction mixture as  negative and positive 
controls respectively. 
Nitric oxide production, based on nitric oxide synthase (NOS) activity, was measured in the control 
and diabetic rat tissues by using a kit 482702 from Calbiochem (CN Biosciences Inc, La Jolla, CA, 
USA)  according  to  the  vendor‟s  protocol.  This  assay  is  based  on  the  measurement  of  total  NO 
produced as the sum of both nitrate and nitrite by Griess reagent in the presence of nitrate reductase, 
NADPH and lactate dehydrogenase. The assay was developed in 96-well ELISA plates using 500 µg 
proteins from control and diabetic rat tissues and the total NO concentration was measured at 540 nm 
using a plate reader spectrophotometer. 
3.4. Assay for Protein Carbonylation 
Protein carbonylation was measured by 2,4-dinitrophenylhydrazine (DNPH) coupling method as 
described by Levine et al. [45]. Briefly, 1.0 mL of assay mixture containing 100 µg proteins from 
mitochondria, microsomes or cytosol from pancreas, liver, kidney and brain from control and diabetic 
rats, in 100 mM phosphate buffer was treated with 2 mM DNPH dissolved in 2N HCl for one hour. 
The TCA-precipitated proteins were washed with a mixture of ethanol-ethyl acetate (1:1) to remove 
free DNPH. The DNPH-coupled carbonylated proteins were then measured spectrophotometrically at 
366 nm and calculated using 22,000 as the molar extinction coefficient. 
3.5. Measurement of Oxygen Uptake 
Succinate-dependent oxygen consumption in freshly prepared mitochondria from pancreas, liver, 
kidney and brain was measured in the absence (State 4) or presence of ADP (State 3) by oxygen meter 
(Model 781 with 1302 Clark-type oxygen electrode) from Strathkelvin Instruments  Ltd (Glasgow, 
UK). Respiratory control rate (RCR) was calculated as the ratio of State 3 over State 4. 
3.6. Assays for Respiratory Complexes 
Activities of mitochondrial respiratory chain complexes (Complex I, II, III and IV) from control 
and diabetic rat tissues were measured using freshly prepared mitochondria as described before [24].  
Aconitase activity was assayed in detergent solubilized mitochondria from control and diabetic rat 
tissues by measuring NADP reduction by citrate in the presence of isocitrate dehydrogenase according 
to the method of Gardner et al. [25]. Briefly, the assay system was developed in 1.0 mL of 50 mM 
Tris-HCl  pH  7.4,  containing  5  mM  sodium  citrate,  0.6  mM  MnCl2,  0.2  mM  NADP,  2  units  of Int. J. Mol. Sci. 2011, 12      3144 
 
 
isocitrate dehydrogenase and 100 µg of mitochondrial protein solubilized with 0.2% lauryl maltoside. 
The enzyme activity was measured spectrophotometrically as NADPH formation at 340 nm. 
3.7. SDS-PAGE and Western Blot Analysis 
Mitochondrial protein (50 µg) from  pancreas,  liver, kidney and brain  of STZ-treated rats  were 
separated on 12% SDS-PAGE [46] and transferred on to nitrocellulose membrane [47] as described 
before  [23].  The  level  of  expression  of  mitochondrial  iNOS,  HO-1  Hsp-70  and  Complex  II  was 
measured by using specific antibodies by Western blot analysis and imaged on a Bio-Rad Versa Doc 
Imaging system. The density of each band was then normalized to the loading control (Tim23) and the 
fold change was calculated and expressed as relative intensity (R.I) compared to control bands, which 
was arbitrarily taken as 1.0. 
3.8. Statistical Analysis 
All the values from control rats (n = 6) and diabetic rats (n = 4) were expressed as mean  S.E.M 
from  three individual experiments.  The  pancreas  was pooled and all the experiments  were run in 
triplicates. Statistical significance of the data and comparison with control were analyzed by Student‟s 
„t‟ test. P values less than 0.05 were considered significant. 
4. Conclusions 
Our  results  suggest  an  increase  in  mitochondrial  metabolic  and  genetic  stress  in  diabetes.  Our 
results  also  suggest  that  increased  mitochondrial  oxidative  stress  is  caused  by  altered  respiratory 
enzyme activities and increased ROS/RNS productions in diabetes. This may have implications in 
understanding the etiology and complications of diabetes. The modulation of mitochondrial respiratory 
and  redox  functions  may  indeed  have  significance  in  mitochondrial  medicine  and  designing 
antioxidant therapeutic strategies. 
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